nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Fluid overload—Carboplatin—brain cancer	0.0653	0.107	CcSEcCtD
Terlipressin—Skin necrosis—Hydroxyurea—brain cancer	0.05	0.0821	CcSEcCtD
Terlipressin—Skin necrosis—Carmustine—brain cancer	0.0404	0.0663	CcSEcCtD
Terlipressin—Skin necrosis—Etoposide—brain cancer	0.0312	0.0513	CcSEcCtD
Terlipressin—Skin exfoliation—Hydroxyurea—brain cancer	0.0167	0.0274	CcSEcCtD
Terlipressin—Pulmonary oedema—Hydroxyurea—brain cancer	0.0155	0.0255	CcSEcCtD
Terlipressin—Cyanosis—Etoposide—brain cancer	0.0154	0.0253	CcSEcCtD
Terlipressin—Respiratory failure—Temozolomide—brain cancer	0.0139	0.0228	CcSEcCtD
Terlipressin—Skin exfoliation—Carmustine—brain cancer	0.0135	0.0221	CcSEcCtD
Terlipressin—Skin exfoliation—Temozolomide—brain cancer	0.013	0.0214	CcSEcCtD
Terlipressin—Hot flush—Temozolomide—brain cancer	0.0106	0.0174	CcSEcCtD
Terlipressin—Menopausal symptoms—Temozolomide—brain cancer	0.0105	0.0172	CcSEcCtD
Terlipressin—Skin exfoliation—Etoposide—brain cancer	0.0104	0.0171	CcSEcCtD
Terlipressin—Hyponatraemia—Carmustine—brain cancer	0.0103	0.0169	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—PTCH2—brain cancer	0.00967	0.0247	CbGpPWpGaD
Terlipressin—AVPR1B—G alpha (q) signalling events—TRPC6—brain cancer	0.00953	0.0243	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.00852	0.0218	CbGpPWpGaD
Terlipressin—Hypertension—Procarbazine—brain cancer	0.00851	0.014	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—OR4C12—brain cancer	0.00848	0.0217	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—OR14C36—brain cancer	0.00848	0.0217	CbGpPWpGaD
Terlipressin—Cardiac failure—Etoposide—brain cancer	0.00812	0.0133	CcSEcCtD
Terlipressin—Vomiting—Lomustine—brain cancer	0.00806	0.0132	CcSEcCtD
Terlipressin—Angiopathy—Hydroxyurea—brain cancer	0.00795	0.0131	CcSEcCtD
Terlipressin—Tachycardia—Procarbazine—brain cancer	0.00785	0.0129	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—OR14C36—brain cancer	0.0077	0.0197	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—OR4C12—brain cancer	0.0077	0.0197	CbGpPWpGaD
Terlipressin—Nausea—Lomustine—brain cancer	0.00753	0.0124	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—PTCH2—brain cancer	0.00671	0.0171	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—PTCH2—brain cancer	0.00666	0.017	CbGpPWpGaD
Terlipressin—AVPR1A—G alpha (q) signalling events—TRPC6—brain cancer	0.00661	0.0169	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00645	0.0106	CcSEcCtD
Terlipressin—AVPR2—Arf6 trafficking events—CTNNB1—brain cancer	0.0064	0.0163	CbGpPWpGaD
Terlipressin—Abdominal pain—Procarbazine—brain cancer	0.00636	0.0105	CcSEcCtD
Terlipressin—Cardiac disorder—Temozolomide—brain cancer	0.00635	0.0104	CcSEcCtD
Terlipressin—Angiopathy—Temozolomide—brain cancer	0.00621	0.0102	CcSEcCtD
Terlipressin—Malnutrition—Carmustine—brain cancer	0.00617	0.0101	CcSEcCtD
Terlipressin—Nervous system disorder—Hydroxyurea—brain cancer	0.00611	0.01	CcSEcCtD
Terlipressin—Skin disorder—Hydroxyurea—brain cancer	0.00605	0.00994	CcSEcCtD
Terlipressin—Acute coronary syndrome—Etoposide—brain cancer	0.00602	0.00989	CcSEcCtD
Terlipressin—Myocardial infarction—Etoposide—brain cancer	0.00598	0.00983	CcSEcCtD
Terlipressin—Malnutrition—Temozolomide—brain cancer	0.00596	0.00979	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.00591	0.0151	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—OR14C36—brain cancer	0.00588	0.015	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—OR4C12—brain cancer	0.00588	0.015	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—OR4C12—brain cancer	0.00584	0.0149	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—OR14C36—brain cancer	0.00584	0.0149	CbGpPWpGaD
Terlipressin—Dyspnoea—Hydroxyurea—brain cancer	0.00555	0.00912	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00554	0.0142	CbGpPWpGaD
Terlipressin—Diarrhoea—Procarbazine—brain cancer	0.00551	0.00905	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00538	0.00883	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—OR4C12—brain cancer	0.00534	0.0136	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—OR14C36—brain cancer	0.00534	0.0136	CbGpPWpGaD
Terlipressin—Hypertension—Carmustine—brain cancer	0.00533	0.00875	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—OR4C12—brain cancer	0.0053	0.0135	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—OR14C36—brain cancer	0.0053	0.0135	CbGpPWpGaD
Terlipressin—Chest pain—Carmustine—brain cancer	0.00525	0.00863	CcSEcCtD
Terlipressin—Hypertension—Temozolomide—brain cancer	0.00515	0.00846	CcSEcCtD
Terlipressin—Vomiting—Procarbazine—brain cancer	0.00512	0.00841	CcSEcCtD
Terlipressin—Cardiac disorder—Etoposide—brain cancer	0.00509	0.00835	CcSEcCtD
Terlipressin—Headache—Procarbazine—brain cancer	0.00504	0.00828	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00504	0.00828	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—SHH—brain cancer	0.00498	0.0127	CbGpPWpGaD
Terlipressin—Angiopathy—Etoposide—brain cancer	0.00497	0.00817	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—PTCH2—brain cancer	0.00496	0.0127	CbGpPWpGaD
Terlipressin—Tachycardia—Carmustine—brain cancer	0.00491	0.00807	CcSEcCtD
Terlipressin—Nausea—Procarbazine—brain cancer	0.00478	0.00785	CcSEcCtD
Terlipressin—Nervous system disorder—Temozolomide—brain cancer	0.00477	0.00784	CcSEcCtD
Terlipressin—Skin disorder—Temozolomide—brain cancer	0.00473	0.00776	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—PTCH1—brain cancer	0.00472	0.0121	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—SMO—brain cancer	0.00472	0.0121	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—OR14C36—brain cancer	0.00455	0.0116	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—OR4C12—brain cancer	0.00455	0.0116	CbGpPWpGaD
Terlipressin—Dyspnoea—Carmustine—brain cancer	0.00449	0.00737	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Carmustine—brain cancer	0.00435	0.00714	CcSEcCtD
Terlipressin—Dyspnoea—Temozolomide—brain cancer	0.00434	0.00713	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—ABR—brain cancer	0.00429	0.011	CbGpPWpGaD
Terlipressin—Diarrhoea—Hydroxyurea—brain cancer	0.00426	0.007	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Temozolomide—brain cancer	0.0042	0.0069	CcSEcCtD
Terlipressin—Hypertension—Etoposide—brain cancer	0.00412	0.00677	CcSEcCtD
Terlipressin—Chest pain—Etoposide—brain cancer	0.00406	0.00667	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00403	0.00663	CcSEcCtD
Terlipressin—Abdominal pain—Carmustine—brain cancer	0.00398	0.00654	CcSEcCtD
Terlipressin—Vomiting—Hydroxyurea—brain cancer	0.00396	0.00651	CcSEcCtD
Terlipressin—Headache—Hydroxyurea—brain cancer	0.0039	0.00641	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—ABR—brain cancer	0.0039	0.00996	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—DTX2—brain cancer	0.00387	0.00989	CbGpPWpGaD
Terlipressin—Abdominal pain—Temozolomide—brain cancer	0.00385	0.00632	CcSEcCtD
Terlipressin—Tachycardia—Etoposide—brain cancer	0.0038	0.00624	CcSEcCtD
Terlipressin—Skin disorder—Etoposide—brain cancer	0.00378	0.00621	CcSEcCtD
Terlipressin—Nausea—Hydroxyurea—brain cancer	0.0037	0.00608	CcSEcCtD
Terlipressin—Dyspnoea—Etoposide—brain cancer	0.00347	0.0057	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—SHH—brain cancer	0.00345	0.00883	CbGpPWpGaD
Terlipressin—Diarrhoea—Carmustine—brain cancer	0.00344	0.00566	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—PTCH2—brain cancer	0.00344	0.00879	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—SHH—brain cancer	0.00343	0.00876	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTCH2—brain cancer	0.00342	0.00873	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Etoposide—brain cancer	0.00336	0.00552	CcSEcCtD
Terlipressin—Diarrhoea—Temozolomide—brain cancer	0.00333	0.00547	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—PTCH1—brain cancer	0.00327	0.00837	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—SMO—brain cancer	0.00327	0.00837	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—SMO—brain cancer	0.00325	0.00831	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—PTCH1—brain cancer	0.00325	0.00831	CbGpPWpGaD
Terlipressin—Vomiting—Carmustine—brain cancer	0.0032	0.00526	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—OR4C12—brain cancer	0.00315	0.00806	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—OR14C36—brain cancer	0.00315	0.00806	CbGpPWpGaD
Terlipressin—Headache—Carmustine—brain cancer	0.00315	0.00518	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—OR4C12—brain cancer	0.00313	0.008	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—OR14C36—brain cancer	0.00313	0.008	CbGpPWpGaD
Terlipressin—Vomiting—Temozolomide—brain cancer	0.00309	0.00508	CcSEcCtD
Terlipressin—Abdominal pain—Etoposide—brain cancer	0.00308	0.00506	CcSEcCtD
Terlipressin—Headache—Temozolomide—brain cancer	0.00305	0.00501	CcSEcCtD
Terlipressin—Nausea—Carmustine—brain cancer	0.00299	0.00491	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—ABR—brain cancer	0.00297	0.0076	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—ABR—brain cancer	0.00295	0.00754	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTCH2—brain cancer	0.00293	0.00749	CbGpPWpGaD
Terlipressin—Nausea—Temozolomide—brain cancer	0.00289	0.00475	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—HES5—brain cancer	0.00284	0.00726	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STRADA—brain cancer	0.00276	0.00705	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—TRPC6—brain cancer	0.00272	0.00694	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—ABR—brain cancer	0.0027	0.0069	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—DTX2—brain cancer	0.00268	0.00685	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—ABR—brain cancer	0.00268	0.00685	CbGpPWpGaD
Terlipressin—Diarrhoea—Etoposide—brain cancer	0.00266	0.00438	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—DTX2—brain cancer	0.00266	0.00681	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00256	0.00654	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—SHH—brain cancer	0.00256	0.00654	CbGpPWpGaD
Terlipressin—Vomiting—Etoposide—brain cancer	0.00248	0.00407	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—TRPC6—brain cancer	0.00247	0.0063	CbGpPWpGaD
Terlipressin—Headache—Etoposide—brain cancer	0.00244	0.00401	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—PTCH1—brain cancer	0.00242	0.0062	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—SMO—brain cancer	0.00242	0.0062	CbGpPWpGaD
Terlipressin—Nausea—Etoposide—brain cancer	0.00231	0.0038	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—ABR—brain cancer	0.0023	0.00588	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GLI2—brain cancer	0.00222	0.00568	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.00218	0.00558	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GLI1—brain cancer	0.00209	0.00534	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—VAV1—brain cancer	0.00203	0.0052	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTCH2—brain cancer	0.00203	0.00519	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTCH2—brain cancer	0.00202	0.00516	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SUFU—brain cancer	0.00198	0.00506	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HES5—brain cancer	0.00197	0.00503	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HES5—brain cancer	0.00195	0.00499	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STRADA—brain cancer	0.00191	0.00488	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GFAP—brain cancer	0.00191	0.00488	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STRADA—brain cancer	0.0019	0.00485	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—TRPC6—brain cancer	0.00188	0.00481	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—TRPC6—brain cancer	0.00187	0.00478	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—VAV1—brain cancer	0.00185	0.00472	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HEY1—brain cancer	0.00181	0.00463	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—DLL1—brain cancer	0.00178	0.00454	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—SHH—brain cancer	0.00177	0.00453	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—SHH—brain cancer	0.00176	0.0045	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—TRPC6—brain cancer	0.00171	0.00437	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—TRPC6—brain cancer	0.0017	0.00434	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—SMO—brain cancer	0.00168	0.00429	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PTCH1—brain cancer	0.00168	0.00429	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—SMO—brain cancer	0.00167	0.00426	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTCH1—brain cancer	0.00167	0.00426	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ABR—brain cancer	0.0016	0.00408	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ABR—brain cancer	0.00158	0.00405	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GLI2—brain cancer	0.00154	0.00394	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GLI2—brain cancer	0.00153	0.00391	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.00151	0.00387	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SHH—brain cancer	0.00151	0.00386	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TRPC6—brain cancer	0.00146	0.00372	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GLI1—brain cancer	0.00145	0.0037	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GLI1—brain cancer	0.00144	0.00367	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTCH1—brain cancer	0.00143	0.00366	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SMO—brain cancer	0.00143	0.00366	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—VAV1—brain cancer	0.00141	0.0036	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—VAV1—brain cancer	0.0014	0.00358	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SUFU—brain cancer	0.00137	0.00351	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SUFU—brain cancer	0.00136	0.00348	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GFAP—brain cancer	0.00132	0.00339	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GFAP—brain cancer	0.00132	0.00336	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CG—brain cancer	0.00129	0.0033	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—VAV1—brain cancer	0.00128	0.00327	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—VAV1—brain cancer	0.00127	0.00325	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HEY1—brain cancer	0.00126	0.00321	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HEY1—brain cancer	0.00125	0.00319	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—DLL1—brain cancer	0.00123	0.00315	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—DLL1—brain cancer	0.00122	0.00312	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CG—brain cancer	0.00117	0.003	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOTCH2—brain cancer	0.00115	0.00293	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VAV1—brain cancer	0.00109	0.00279	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SHH—brain cancer	0.00105	0.00268	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SHH—brain cancer	0.00104	0.00266	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TRPC6—brain cancer	0.00101	0.00258	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TRPC6—brain cancer	0.001	0.00256	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTCH1—brain cancer	0.000993	0.00254	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SMO—brain cancer	0.000993	0.00254	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SMO—brain cancer	0.000986	0.00252	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTCH1—brain cancer	0.000986	0.00252	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HES1—brain cancer	0.000939	0.0024	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2—brain cancer	0.000909	0.00232	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CG—brain cancer	0.000896	0.00229	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PDGFRA—brain cancer	0.000894	0.00228	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CG—brain cancer	0.000889	0.00227	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SPP1—brain cancer	0.000868	0.00222	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2—brain cancer	0.000826	0.00211	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CG—brain cancer	0.000813	0.00208	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CG—brain cancer	0.000807	0.00206	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOTCH2—brain cancer	0.000794	0.00203	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOTCH2—brain cancer	0.000788	0.00201	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IRS2—brain cancer	0.000785	0.00201	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VAV1—brain cancer	0.000757	0.00193	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VAV1—brain cancer	0.000751	0.00192	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CG—brain cancer	0.000693	0.00177	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APC—brain cancer	0.000693	0.00177	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HES1—brain cancer	0.000651	0.00166	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HES1—brain cancer	0.000646	0.00165	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EGFR—brain cancer	0.000631	0.00161	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—brain cancer	0.00063	0.00161	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—brain cancer	0.000626	0.0016	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PDGFRA—brain cancer	0.00062	0.00158	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PDGFRA—brain cancer	0.000615	0.00157	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SPP1—brain cancer	0.000602	0.00154	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SPP1—brain cancer	0.000597	0.00153	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—brain cancer	0.000572	0.00146	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—brain cancer	0.000568	0.00145	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IRS2—brain cancer	0.000544	0.00139	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RELA—brain cancer	0.000542	0.00138	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IRS2—brain cancer	0.00054	0.00138	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB2—brain cancer	0.000538	0.00138	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—brain cancer	0.000488	0.00125	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APC—brain cancer	0.00048	0.00123	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CG—brain cancer	0.00048	0.00123	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APC—brain cancer	0.000477	0.00122	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CG—brain cancer	0.000477	0.00122	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCND1—brain cancer	0.000475	0.00121	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CTNNB1—brain cancer	0.000471	0.0012	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EGFR—brain cancer	0.000438	0.00112	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EGFR—brain cancer	0.000435	0.00111	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—brain cancer	0.000415	0.00106	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—brain cancer	0.00041	0.00105	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—brain cancer	0.000381	0.000975	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RELA—brain cancer	0.000375	0.000959	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB2—brain cancer	0.000373	0.000953	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGFR—brain cancer	0.000373	0.000953	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RELA—brain cancer	0.000373	0.000952	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB2—brain cancer	0.00037	0.000946	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—brain cancer	0.000338	0.000864	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—brain cancer	0.000336	0.000858	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCND1—brain cancer	0.00033	0.000842	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCND1—brain cancer	0.000327	0.000836	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CTNNB1—brain cancer	0.000326	0.000834	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CTNNB1—brain cancer	0.000324	0.000828	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—brain cancer	0.000313	0.0008	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—brain cancer	0.000287	0.000734	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—brain cancer	0.000285	0.000729	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—brain cancer	0.000284	0.000727	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—brain cancer	0.000282	0.000722	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—brain cancer	0.000264	0.000675	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—brain cancer	0.000262	0.000671	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGFR—brain cancer	0.000259	0.000661	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGFR—brain cancer	0.000257	0.000656	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—brain cancer	0.000217	0.000555	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—brain cancer	0.000216	0.000551	CbGpPWpGaD
